Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Read Aloud is a digital health and assistive technology company that provides advanced text-to-speech (TTS) solutions designed to improve accessibility for individuals with print disabilities, including dyslexia, visual impairments, and ADHD. The company's primary product is a widely used browser extension and online service that converts digital text from websites, PDFs, and documents into natural-sounding audio. By leveraging AI-driven voice synthesis, Read Aloud enables users to consume scientific, medical, and educational content hands-free, fostering better comprehension and retention. The technology is frequently integrated into healthcare portals and pharmaceutical websites to ensure equitable access to patient information and clinical trial documentation. Read Aloud serves a global user base, supporting dozens of languages and natural-sounding voices to bridge communication and literacy gaps in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Read Aloud.